Newsletter Signup | Join Community
Cancer Connect - Treatment of Recurrent Multiple Myeloma
Following Fast Track Designation from FDA Xpovio receives approval for treatment of Multiple Myeloma
Darzalex is effective myeloma treatment in several settings - most recently for transplant ineligible patients.
Revlimid can delay progression of smoldering myeloma to multiple myeloma but not without side effects.
Amgen releases initial data on AMG 420 Immunotherapy and the initial results in multiple myeloma look very good
Understand the evolution and of role of stem cell transplant treatment in newly diagnosed multiple myeloma .
May 2019 update on CAR T in multiple myeloma and other targeted therapies. CAR T looks very promising.
Has anyone elected to receive triple drug therapy and delay their ASCT? Seems like there is…
New Antibody that targets CD74 on myeloma cells gets nod from FDA to proceed. …
UK doctors identify a new target for treating Multiple Myeloma: …